113 related articles for article (PubMed ID: 24165752)
21. Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer.
Skoczen SL; Stern ST
Methods Mol Biol; 2018; 1682():223-239. PubMed ID: 29039106
[TBL] [Abstract][Full Text] [Related]
22. Loss of propranolol during ultrafiltration in plasma protein binding studies.
Parsons DL; Fan HF
Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):405-8. PubMed ID: 3797814
[TBL] [Abstract][Full Text] [Related]
23. Determination of drug plasma protein binding by solid phase microextraction.
Musteata FM; Pawliszyn J; Qian MG; Wu JT; Miwa GT
J Pharm Sci; 2006 Aug; 95(8):1712-22. PubMed ID: 16795010
[TBL] [Abstract][Full Text] [Related]
24. Drug-protein-binding determination of stilbene glucoside using cloud-point extraction and comparison with ultrafiltration and equilibrium dialysis.
Wang C; Wang Q; Yuan Z; Liu W; Gu J; Zhang L
Drug Dev Ind Pharm; 2010 Mar; 36(3):307-14. PubMed ID: 19670965
[TBL] [Abstract][Full Text] [Related]
25. Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry.
Cheng Y; Ho E; Subramanyam B; Tseng JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):67-73. PubMed ID: 15282095
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic drug monitoring of free vancomycin concentration in practice: A new analytical technique based on the HFCF-UF sample separation method.
Ren F; Liu Y; Li S; Li X; Wu X; Li Y; Zhang Z
Biomed Chromatogr; 2023 Mar; 37(3):e5559. PubMed ID: 36478261
[TBL] [Abstract][Full Text] [Related]
27. Vacuum ultrafiltration sampling for determination of plasma protein binding of drugs.
Lam H; Davies M; Lunte CE
J Pharm Biomed Anal; 1996 Sep; 14(12):1753-7. PubMed ID: 8887723
[No Abstract] [Full Text] [Related]
28. Measurement and analysis of unbound drug concentrations.
Wright JD; Boudinot FD; Ujhelyi MR
Clin Pharmacokinet; 1996 Jun; 30(6):445-62. PubMed ID: 8792057
[TBL] [Abstract][Full Text] [Related]
29. Determination of atypical nonlinear plasma−protein-binding behavior of tigecycline using an in vitro microdialysis technique.
Mukker JK; Singh RP; Derendorf H
J Pharm Sci; 2014 Mar; 103(3):1013-9. PubMed ID: 24549736
[TBL] [Abstract][Full Text] [Related]
30. [Determination of protein binding of drugs using equilibrium dialysis. Influence of volume displacement caused by osmotic pressure].
Lapicque F; Netter P; Monot C; Bannwarth B; Maknassi MS; Royer RJ
J Pharmacol; 1986; 17(3):295-300. PubMed ID: 3795973
[TBL] [Abstract][Full Text] [Related]
31. Compilation of 222 drugs' plasma protein binding data and guidance for study designs.
Zhang F; Xue J; Shao J; Jia L
Drug Discov Today; 2012 May; 17(9-10):475-85. PubMed ID: 22210121
[TBL] [Abstract][Full Text] [Related]
32. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
Tillement JP; Duché JC; Barré J
Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
[TBL] [Abstract][Full Text] [Related]
33. New aspects of free drug concentration determination in human serum with equilibrium dialysis.
van der Giesen WF; Wilting J
Methods Find Exp Clin Pharmacol; 1982; 4(6):417-23. PubMed ID: 7144334
[TBL] [Abstract][Full Text] [Related]
34. Protein binding of aspirin and salicylate measured by in vivo ultrafiltration.
Ghahramani P; Rowland-Yeo K; Yeo WW; Jackson PR; Ramsay LE
Clin Pharmacol Ther; 1998 Mar; 63(3):285-95. PubMed ID: 9542472
[TBL] [Abstract][Full Text] [Related]
35. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay.
Frystyk J; Ivarsen P; Støving RK; Dall R; Bek T; Hagen C; Ørskov H
Growth Horm IGF Res; 2001 Apr; 11(2):117-27. PubMed ID: 11472078
[TBL] [Abstract][Full Text] [Related]
36. On the distribution of drugs in saliva and blood plasma.
Feller K; le Petit G
Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):468-9. PubMed ID: 21854
[TBL] [Abstract][Full Text] [Related]
37. One-step method for plasma determination of ibuprofen by chemiluminescence-coupled ultrafiltration and application in a pharmacokinetic study.
Xiong X; Zhang Q; Nan Y; Gu X
Luminescence; 2012; 27(5):371-8. PubMed ID: 21984391
[TBL] [Abstract][Full Text] [Related]
38. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.
Pacifici GM; Viani A
Clin Pharmacokinet; 1992 Dec; 23(6):449-68. PubMed ID: 1458763
[TBL] [Abstract][Full Text] [Related]
39. Analysis of total and unbound hydromorphone in human plasma by ultrafiltration and LC-MS/MS: application to clinical trial in patients undergoing open heart surgery.
Saari TI; Fechner J; Ihmsen H; Schüttler J; Jeleazcov C
J Pharm Biomed Anal; 2012 Dec; 71():63-70. PubMed ID: 22884788
[TBL] [Abstract][Full Text] [Related]
40. [Determination of plasma protein binding rate of tetramethylpyrazine phosphate by ultrafiltration].
Ye Y; Zhou LL; Yan YL; Huang QJ
Zhong Yao Cai; 2010 Aug; 33(8):1282-5. PubMed ID: 21213541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
